Company intelligence / Profile preview
CinFina Pharma
Cincinnati, Ohio, United Statescinfina.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
CinFina Pharma is advancing four therapeutic candidates for obesity and metabolic diseases. Its lead program CIN‑109, a GDF‑15 analog, has completed Phase 1 multiple ascending dose studies with positive safety/tolerability data. CIN‑110, a selective PYY 3–36 analog, has entered Phase 1 trials after promising preclinical results. The pipeline also includes dual agonist programs combining GLP‐1 with either GDF‐15 or PYY 3–36 to enhance efficacy and tolerability for weight loss therapies.
- Therapeutic areas
- Metabolic DisordersEndocrinology
- Modalities
- Synthetic peptidesRecombinant polypeptidesPeptide analogs (GDF15 analogs, PYY 3–36 analogs)Dual agonists (e.g., GLP‑1 + GDF‑15 or PYY 3–36 + GLP‑1)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
No major external pharma partnerships disclosed; closely integrated with parent organization CinRx.
Beyond the preview
Go deeper on CinFina Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CinFina Pharma.